Obstructive sleep apnea (OSA) and obesity
Clinical trials for Obstructive sleep apnea (OSA) and obesity explained in plain language.
Never miss a new study
Get alerted when new Obstructive sleep apnea (OSA) and obesity trials appear
Sign up with your email to follow new studies for Obstructive sleep apnea (OSA) and obesity, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a weekly shot ease sleep apnea and shed weight?
Disease control Not yet recruitingThis trial tests whether an investigational drug called HDM1005, given as a weekly injection, can help people with obstructive sleep apnea and obesity. Participants will receive either HDM1005 or a placebo for 52 weeks, alongside lifestyle counseling on diet and physical activity…
Matched conditions: OBSTRUCTIVE SLEEP APNEA (OSA) AND OBESITY
Phase 3 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a weekly shot ease sleep apnea and shed pounds?
Disease control Not yet recruitingThis phase 3 trial is testing whether an investigational drug called HDM1005, given as a once-weekly injection, can improve obstructive sleep apnea and reduce body weight in people with obesity who do not use positive airway pressure (PAP) therapy. About 200 adults aged 18 to 75 …
Matched conditions: OBSTRUCTIVE SLEEP APNEA (OSA) AND OBESITY
Phase 3 • Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC